Jeanne Hejna
Overview
Explore the profile of Jeanne Hejna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
255
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghanim H, Batra M, Green K, Hejna J, Abuaysheh S, Makdissi A, et al.
Diabetes Obes Metab
. 2021 Mar;
23(7):1614-1623.
PMID: 33729664
Aim: To investigate the mechanisms underlying improvements in blood pressure (BP) and congestive heart failure outcomes following treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor. Research Design And Methods: A total...
2.
Ghanim H, Batra M, Green K, Abuaysheh S, Hejna J, Makdissi A, et al.
Diabetes Obes Metab
. 2020 May;
22(10):1742-1752.
PMID: 32424935
Aim: To investigate the effects of liraglutide treatment on glycaemic control and adipose tissue metabolism in overweight and obese people with type 1 diabetes (T1DM). Research Design And Methods: A...
3.
Ghanim H, Abuaysheh S, Hejna J, Green K, Batra M, Makdissi A, et al.
J Clin Endocrinol Metab
. 2020 Feb;
105(4).
PMID: 32044999
Context: Dapagliflozin and other SGLT2 inhibitors are known to increase hematocrit, possibly due to its diuretic effects and hemoconcentration. Objective: Since type 2 diabetes is a proinflammatory state and since...
4.
Garg M, Ghanim H, Kuhadiya N, Green K, Hejna J, Abuaysheh S, et al.
Diabetes Obes Metab
. 2017 Mar;
19(9):1306-1311.
PMID: 28304146
In view of the occurrence of diabetic ketoacidosis associated with the use of sodium-glucose transport protein-2 inhibitors in patients with type 1 diabetes (T1DM) and the relative absence of this...
5.
Kuhadiya N, Ghanim H, Mehta A, Garg M, Khan S, Hejna J, et al.
J Clin Endocrinol Metab
. 2016 Aug;
101(9):3506-15.
PMID: 27490915
Context: It is imperative that novel approaches to treatment of type 1 diabetes (T1D) are devised. Objective: The objective of the study was to investigate whether addition of dapagliflozin to...
6.
Kuhadiya N, Dhindsa S, Ghanim H, Mehta A, Makdissi A, Batra M, et al.
Diabetes Care
. 2016 May;
39(6):1027-35.
PMID: 27208343
Objective: To investigate whether addition of three different doses of liraglutide to insulin in patients with type 1 diabetes (T1D) results in significant reduction in glycemia, body weight, and insulin...
7.
Dhindsa S, Ghanim H, Batra M, Kuhadiya N, Abuaysheh S, Sandhu S, et al.
Diabetes Care
. 2015 Dec;
39(1):82-91.
PMID: 26622051
Objective: One-third of men with type 2 diabetes have hypogonadotropic hypogonadism (HH). We conducted a randomized placebo-controlled trial to evaluate the effect of testosterone replacement on insulin resistance in men...